Northwest Biotherapeutics, Inc.
NWBO
$0.23
$0.00-0.78%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.83M | -15.38M | -19.34M | -28.22M | -19.37M |
| Total Depreciation and Amortization | 521.00K | 517.00K | 498.00K | 501.00K | 522.00K |
| Total Amortization of Deferred Charges | 414.00K | 525.00K | 334.00K | 858.00K | 551.00K |
| Total Other Non-Cash Items | 9.35M | 2.78M | 2.71M | 4.60M | 6.27M |
| Change in Net Operating Assets | 2.65M | 4.87M | 6.38M | 2.09M | 3.80M |
| Cash from Operations | -13.89M | -6.69M | -9.42M | -20.18M | -8.23M |
| Capital Expenditure | -202.00K | -304.00K | -93.00K | -78.00K | -176.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -311.00K | -- | -- | -- | -- |
| Cash from Investing | -513.00K | -304.00K | -93.00K | -78.00K | -176.00K |
| Total Debt Issued | 7.18M | 5.31M | 7.20M | 12.10M | 5.02M |
| Total Debt Repaid | -479.00K | -184.00K | -607.00K | -382.00K | -802.00K |
| Issuance of Common Stock | 4.86M | 7.33M | 5.14M | 4.22M | 7.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 267.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 11.56M | 12.45M | 11.73M | 15.94M | 11.62M |
| Foreign Exchange rate Adjustments | 3.09M | -3.92M | -1.62M | 3.55M | -3.15M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 244.00K | 1.54M | 604.00K | -764.00K | 58.00K |